Showing results (1-10 of 177) with videos related to
Sort By:
Pageof 18
Nature Communications|August 5, 2025
The hidden risks of CRISPR/Cas: structural variations and genome integrityClotilde Aussel, Toni Cathomen, Carla Fuster-GarcíaHuman Gene Therapy|July 2, 2026
Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational PerspectivesGhazale Minaiyan, Clotilde Aussel, Sandra Ammann, et al.Current Opinion in Molecular Therapeutics|October 8, 2004
AAV vectors for gene correctionToni CathomenMolecular Therapy. Nucleic Acids|August 8, 2025
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challengesNechama Kalter, Carla Fuster-García, Alfredo Silva, et al.Deutsches Arzteblatt International|February 27, 2021
Gene Therapy for Monogenic Inherited DisordersJanbernd Kirschner, Toni CathomenNature Methods|September 1, 2011
On target? Tracing zinc-finger-nuclease specificityClaudio Mussolino, Toni CathomenCurrent Opinion in Biotechnology|February 21, 2012
TALE nucleases: tailored genome engineering made easyClaudio Mussolino, Toni CathomenMethods in Molecular Biology (Clifton, N.J.)|August 4, 2010
In vitro assessment of zinc finger nuclease activityToni Cathomen, Cem SöllüCurrent Opinion in Molecular Therapeutics|June 7, 2008
Genotoxicity in gene therapy: an account of vector integration and designer nucleasesJens Bohne, Toni CathomenMolecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2007
Targeted genome modifications using integrase-deficient lentiviral vectorsTatjana I Cornu, Toni CathomenPageof 18